Inactive Instrument

Company PCAS

Equities

PCA

FR0000053514

Pharmaceuticals

Business Summary

PCAS specializes in developing, manufacturing, and marketing fine and specialty chemicals. Sales are distributed by family of products as follows:

- synthesized pharmaceutical products (63.5%);

- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).

At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.

France accounts for 76% of net sales.

Number of employees: 1,178

Managers

Managers TitleAgeSince
Director of Finance/CFO - -
Chairman 60 17-06-19
Chief Tech/Sci/R&D Officer - 99-02-28

Members of the board

Members of the board TitleAgeSince
Chairman 60 17-06-19
Director/Board Member 72 14-02-28
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 15,141,725 1,073,700 ( 7.091 %) 1,400,052 ( 9.246 %) 7.091 %

Shareholders

NameEquities%Valuation
Seqens SAS
95.62 %
14,478,339 95.62 % 124 M €
Inocap Gestion SAS (Investment Management)
1.117 %
169,149 1.117 % 1 M €
Gay-Lussac Gestion SA
1.036 %
156,818 1.036 % 1 M €
Inocap Gestion SAS
0.5469 %
82,812 0.5469 % 711 819 €

Company contact information

PCAS SA

21, Chemin de la Sauvegarde

69134, Écully

+33 1 69 09 77 85

http://www.pcas.com
address PCAS(PCA)